SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION

The present invention relates specific activation of a regulatory T cell via a specific CD4 epitope and uses thereof, e.g. for the treatment of an autoimmune disease or an allergy or asthma or graft rejection or tolerance induction. La présente invention porte sur l'activation spécifique d'...

Full description

Saved in:
Bibliographic Details
Main Authors JONULEIT, HELMUT, SCHMITT, EDGAR, BOPP, TOBIAS, SCHNEIDER, FRANZ-JOSEF, BECKER, CHRISTIAN
Format Patent
LanguageEnglish
French
Published 05.01.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates specific activation of a regulatory T cell via a specific CD4 epitope and uses thereof, e.g. for the treatment of an autoimmune disease or an allergy or asthma or graft rejection or tolerance induction. La présente invention porte sur l'activation spécifique d'un lymphocyte T régulateur par l'intermédiaire d'un épitope CD4 spécifique et sur ses utilisations, par exemple pour le traitement d'une maladie auto-immune ou d'une allergie ou de l'asthme ou du rejet de greffe ou d'une induction de tolérance.
Bibliography:Application Number: CA20082676170